Zobrazeno 1 - 8
of 8
pro vyhledávání: '"K N, Simpson"'
Autor:
K N, Simpson, S-Y, Chen, A W, Wu, L, Boulanger, R, Chambers, K, Nedrow, M, Tawadrous, C L, Pashos, S, Haider
Publikováno v:
HIV medicine. 15(8)
The aim of the study was to assess the incidence and costs of adverse events (AEs) among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors (NNRTIs) from the health care system perspective.US medical and pharmacy
Autor:
B. P. Yawn, E. J. Roth, D. Krotoski, B. Ansel, G. D. Fischbach, H. D. Sigmon, W. B. Jonas, D. Heppel, R. M. Ruff, J. H. Ferguson, John D. Corrigan, M. E. Cheung, Allen W. Heinemann, M. Coopey, J. M. Whalen, V. W. Pinn, B. D. Jordan, W. T. Greenough, David J. Thurman, J. M. Eisenberg, M. Ylvisaker, M. A. Riddle, K. N. Simpson, S. M. Tuel, J. S. Kreutzer, W. R. Clarke, M. M. Seltzer, S. E. Hyman, Kristjan T. Ragnarsson, B. E. Wexler, T. S. Lawrence, G. Cheung, C. R. Sherman, J F Jr Batley, William H. Hall, A. Salazar, S. L. Garber, M. V. Johnston, B. Vitiello, J. F. Kraus, D. N. Cope, C. E. Henderson, J. P. Koplan, J. R. Daling, J. Banja, C. F. Gustafson, B. Therrien, P. A. Grady, Kenneth J. Ottenbacher, J. M. Elliott, Mitchell Rosenthal, M. J. Fuhrer, J. Whyte, George P. Prigatano, D. D. Cardenas, G. A. Zitnay, D. Alexander, R. M. Chesnut, G. DeJong, H. S. Levin, D. T. Stuss, A. L. Holland, T. M. Rankin, J. T. Povlishock, J. C. Parker, D. Lehmkuhl, Tracy K. McIntosh
Publikováno v:
JAMA: The Journal of the American Medical Association. 282:974-983
Autor:
K N Simpson, M C Portela
Publikováno v:
Memórias do Instituto Oswaldo Cruz., Vol 92, Iss 4, p 437 (1997)
This paper is aimed at providing a comprehensive review of markers, cofactors and staging systems used for HIV disease, focusing on some aspects that nowadays could even be considered historical, and advancing in current issues such as the prognostic
Publikováno v:
Seminars in hematology. 35(1 Suppl 1)
A retrospective study was conducted to determine treatment patterns for idiopathic thrombocytopenia purpura (ITP) across the US and to determine the cost of its treatment with high-dose intravenous immunoglobulin (IVIg) and anti-D therapy. Informatio
Publikováno v:
MLO: medical laboratory observer. 28(2)
Autor:
K N, Simpson
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 10
Cost-effectiveness (CE) ratios are indicators of comparative efficiency of competing drugs. Unfortunately, they are subject to variations, depending on factors such as the study population chosen, the comparison treatment selected, and the economic a
Autor:
K N, Simpson
Publikováno v:
The Journal of urology. 152(5 Pt 2)
Publikováno v:
Clinical laboratory management review : official publication of the Clinical Laboratory Management Association. 5(6)
Total Quality Management (TQM) is a continuous quality improvement process that evaluates processes from a customer satisfaction point-of-view. The aim is continuous process improvement. TQM is a paradigm shift for most health-care organizations and